Autocrine overexpression of CTGF maintains fibrosis: RDA analysis of fibrosis genes in systemic sclerosis

Experimental Cell Research

Volumn 259, Issue 1, 2000, Pages 213-224

  Shi wen, X ^a   Pennington, D ^b   Holmes, A ^a   Leask, A ^e   Bradham, D ^e   Beauchamp, J R ^c   Fonseca, C ^a   Du Bois, R M ^d   Martin, G R ^e   Black, C M ^a   Abraham, D J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b IMPERIAL CANCER RESEARCH FUND   (United Kingdom)

^c IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

^d ROYAL BROMPTON HOSPITAL   (United Kingdom)

^e FIBROGEN INC   (United States)

Author keywords

CTGF; Fibroblasts; Fibrosis; Systemic sclerosis; TGF

Indexed keywords

COLLAGEN TYPE 1; COMPLEMENTARY DNA; CONNECTIVE TISSUE GROWTH FACTOR; FIBRONECTIN; PROCOLLAGEN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ARTICLE; AUTOCRINE EFFECT; CONTROLLED STUDY; DNA DETERMINATION; DNA LIBRARY; DNA TRANSFECTION; FIBROGENESIS; GENE ACTIVATION; GENE DELETION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; LUNG LAVAGE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN INDUCTION; REPORTER GENE; SKIN FIBROBLAST; SYSTEMIC SCLEROSIS; TRANSCRIPTION REGULATION;

ANIMALIA; CUCUMBER MOSAIC VIRUS; SCLERODERMA; TRIXIS;

EID: 0034714517     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4972     Document Type: Article

References (38)

1. Systemic sclerosis and related disorders
2. Increased collagen synthesis by scleroderma skin fibroblasts in vitro: A possible defect in the regulation or activation of the scleroderma fibroblast
3. Increased expression of TGF-beta receptors by scleroderma fibroblasts: Evidence for contribution of autocrine TGF-beta signaling to scleroderma phenotype
4. Cloning the differences between two complex genomes
5. Identifying differences in mRNA expression by representational difference analysis of cDNA
6. The transcription factor GATA-3 is necessary and sufficient for Th2 cytokin gene expression in CD4 T cells
7. The connective tissue growth factor/cysteine-rich 61/nephroblastoma overexpressed (CCN) family
8. The CCN family of angiogenic regulators: The integrin connection
9. Connective tissue growth factor: A cysteine-rich mitogen secreted by human vascular endothelial cells is related to the SRC-induced immediate early gene product CEF-10
10. Connective tissue growth factor: Friend or foe?
11. Cloning of a mRNA perferentially expressed in chondrocytes by differential display - PCR from a human chondrocytic cell line that is identical with connective tissue growth factor (CTGF) mRNA
12. Localization of connective tissue growth factor during the period of embryoimplantation in the mouse
13. Regulation of connective tissue growth factor gene expression in human skin fibroblasts and during wound repair
14. A novel transforming growth factor beta response element controls the expression of the connective tissue growth factor gene
15. Significant correlation between connective tissue growth factor gene expression and skin sclerosis in tissue sections from patients with systemic sclerosis
16. Connective tissue growth factor gene expression in tissue sections from localized systemic sclerosis, keloid, and other fibrotic skin disorders
17. Stimulation of fibroblast cell growth, matrix production, and granulation tissue formation by connective tissue growth factor
18. Role and interaction of connective tissue growth factor with transforming growth factor-beta in persistent fibrosis: A mouse fibrosis model
19. Increased levels of endothelin-1 in bronchoalveolar lavage fluid from patients with systemic sclerosis, contribute to fibroblast mitogenic activity in vitro
20. Systemic sclerosis lung fibroblasts exhibit elevated and dysregulated collagen type I biosynthesis
21. Establishment of the enzyme-linked immunosorbent assay for connective tissue growth factor (CTGF) and its detection in the sera of biliary atresia
22. Serum levels of connective tissue growth factor are elevated in patients with systemic sclerosis: Association with extent of skin sclerosis and severity of pulmonary fibrosis
23. Expression and role of IL-15 in post-burn hypertrophic scars
24. Identification of multiple, differentially expressed messenger RNAs in dermal fibroblasts from patients with systemic sclerosis
25. Thymosin beta4 accelerates wound healing
26. Pathogenesis of scleroderma. Collagen
27. Immunohistochemical localisation of transforming growth factor beta 1 and type I procollagen in limited (lcSystemic sclerosis), diffuse (dc-Systemic sclerosis) systemic sclerosis and morphea
28. Spontaneous increase of transforming growth factor-beta production by bronchoalveolar mononuclear cells of patients with systemic autoimmune diseases affecting the lung
29. Collagen type I is not under autocrine control by transforming growth factor-beta in normal and acleroderma fibroblasts
30. TGF-beta: From latent to active
31. Growth regulation in systemic sclerosis fibroblasts: Increased response to transforming growth factor-β
32. A preliminary study of long-term treatment with interferon gamma-1b and low-dose prednisolone in patients with idiopathic pulmonary fibrosis
33. Identification of glycosylated 38-Kda connective tissue growth factor (IGFBP-related protein 2) and proteolytic fragments in human biological fluids, and up-regulation of IGFBP-rP2 expression by TGF-beta in Hs578T human cancer cells
34. Connective tissue growth factor (IGFBP-rP2) expression and regulation in cultured bovine endothelial cells
35. Transforming growth factor-β induces anchorage-independent growth of NRK fibroblasts via a connective tissue growth factor-dependent signaling pathway
36. Inhibition of TGF-beta-stimulated CTGF gene expression and anchorage-independent growth by cAMP identifies a CTGF-dependent restriction point in the cell cycle
37. Regulation of human lung fibroblast alpha 1(I) procollagen gene expression by tumor necrosis factor alpha, interleukin-1 beta, and prostaglandin E2